{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:59:04Z","timestamp":1781729944795,"version":"3.54.5"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vph.2023.107210","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T11:36:30Z","timestamp":1692617790000},"page":"107210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Exploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of disease"],"prefix":"10.1016","volume":"152","author":[{"given":"Stefano","family":"Quarta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Santarpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Annunziata","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Calabriso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Siculella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Damiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vph.2023.107210_bb0005","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jacc.2007.06.024","article-title":"Insights into degenerative Aortic valve disease","volume":"50","author":"Goldbarg","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0010","first-page":"1004","article-title":"Left ventricular Remodelling in Aortic stenosis","volume":"30","author":"Rassi","year":"2014","journal-title":"Can. J. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2310\/6650.2007.00010","article-title":"Epidemiology and genetics of calcific aortic valve disease","volume":"55","author":"O\u2019Brien","year":"2007","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.vph.2023.107210_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2023-322397","article-title":"Mortality trends of aortic stenosis in high-income countries from 2000 to 2020","author":"Hibino","year":"2023","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.vph.2023.107210_bb0025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.vph.2023.107210_bb0030","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.vph.2023.107210_bb0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.athoracsur.2010.11.009","article-title":"Fifteen-year outcome trends for valve surgery in North America","volume":"91","author":"Lee","year":"2011","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.vph.2023.107210_bb0045","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","article-title":"Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"101","author":"Ren","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2023.107210_bb0050","first-page":"32B","article-title":"The \u2018valvulo-metabolic\u2019 risk in calcific aortic valve disease","volume":"23","author":"Mathieu","year":"2007","journal-title":"Can. J. Cardiol."},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"10.1016\/j.vph.2023.107210_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2023.06.002","article-title":"The common pathobiology between coronary artery disease and calcific aortic stenosis: evidence and clinical implications","author":"Abdul-Rahman","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0070","first-page":"489","article-title":"Aortic stenosis: insights on pathogenesis and clinical implications","volume":"13","author":"Carit\u00e0","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.vph.2023.107210_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.765419","article-title":"Pathogenesis and molecular immune mechanism of calcified Aortic valve disease","volume":"8","author":"Bian","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.vph.2023.107210_bb0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","article-title":"Calcification in Aortic stenosis: the skeleton key","volume":"66","author":"Pawade","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1484","key":"10.1016\/j.vph.2023.107210_bb0085","first-page":"1421","article-title":"Heart valve macro- and microstructure","volume":"362","author":"Misfeld","year":"2007","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.vph.2023.107210_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114775","article-title":"Oxidative stress and valvular endothelial cells in aortic valve calcification","volume":"163","author":"Shu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cvr\/cvt040","article-title":"Biomechanical factors in the biology of aortic wall and aortic valve diseases","volume":"99","author":"B\u00e4ck","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM198707093170206","article-title":"Changing aspects of the natural history of valvular aortic stenosis","volume":"317","author":"Selzer","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0105","first-page":"165","article-title":"Side-specific expression of activated leukocyte adhesion molecule (ALCAM; CD166) in pathosusceptible regions of swine aortic valve endothelium","volume":"20","author":"Guerraty","year":"2011","journal-title":"J Heart Valve Dis"},{"issue":"7","key":"10.1016\/j.vph.2023.107210_bb0110","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0735-1097(00)00998-0","article-title":"Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement","volume":"36","author":"Ghaisas","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/CIRCRESAHA.121.318011","article-title":"Inflammatory and biomechanical drivers of endothelial-interstitial interactions in calcific Aortic valve disease","volume":"128","author":"Driscoll","year":"2021","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.vph.2023.107210_bb0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrcardio.2014.162","article-title":"Cardiac valve cells and their microenvironment--insights from in vitro studies","volume":"11","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCRESAHA.113.300155","article-title":"Molecular and cellular aspects of calcific aortic valve disease","volume":"113","author":"Towler","year":"2013","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.vph.2023.107210_bb0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/eurheartj\/ehi248","article-title":"Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors","volume":"26","author":"Fondard","year":"2005","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0135","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.athoracsur.2006.10.026","article-title":"Transforming growth factor-\u03b21 mechanisms in Aortic valve calcification: increased alkaline phosphatase and related events","volume":"83","author":"Clark-Greuel","year":"2007","journal-title":"Ann. Thorac. Surg."},{"issue":"22","key":"10.1016\/j.vph.2023.107210_bb0140","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020913","article-title":"Extracellular matrix in calcific Aortic valve disease: architecture, dynamic and perspectives","volume":"22","author":"Di Vito","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0150","first-page":"183","article-title":"Endothelial-to-mesenchymal transition in calcific Aortic valve disease","volume":"36","author":"Ma","year":"2020","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.15420\/ecr.2015.10.2.108","article-title":"Calcific Aortic valve disease: molecular mechanisms and therapeutic approaches","volume":"10","author":"Lerman","year":"2015","journal-title":"Eur Cardiol"},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0160","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1159\/000366400","article-title":"Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt\/\u03b2-catenin pathway","volume":"34","author":"Rong","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.vph.2023.107210_bb0165","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/jech-2015-206948","article-title":"The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis","volume":"70","author":"Zheng","year":"2016","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.vph.2023.107210_bb0170","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fcell.2020.00862","article-title":"The role of Wnt\/beta-catenin pathway mediators in Aortic valve stenosis","volume":"8","author":"Khan","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.vph.2023.107210_bb0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCINTERVENTIONS.112.971028","article-title":"Cellular mechanisms of aortic valve calcification","volume":"5","author":"Leopold","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.vph.2023.107210_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2022.10.010","article-title":"An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis","volume":"174","author":"Lewis","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0185","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s10439-016-1567-9","article-title":"Valve interstitial cells act in a Pericyte manner promoting Angiogensis and invasion by valve endothelial cells","volume":"44","author":"Arevalos","year":"2016","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.vph.2023.107210_bb0190","article-title":"Contributions of the endothelium to vascular calcification","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Develop. Biol."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jjcc.2017.11.007","article-title":"Mechanisms of aortic stenosis","volume":"71","author":"Akahori","year":"2018","journal-title":"J. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pcad.2014.02.006","article-title":"The global burden of aortic stenosis","volume":"56","author":"Thaden","year":"2014","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.anclin.2009.07.012","article-title":"Aortic valve stenosis","volume":"27","author":"Zigelman","year":"2009","journal-title":"Anesthesiol. Clin."},{"issue":"13","key":"10.1016\/j.vph.2023.107210_bb0210","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2023.107210_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/hrt.2010.192997","article-title":"Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis","volume":"97","author":"Cioffi","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.vph.2023.107210_bb0220","doi-asserted-by":"crossref","first-page":"1216783","DOI":"10.1155\/2016\/1216783","article-title":"Differential role of adipose tissues in obesity and related metabolic and vascular complications","volume":"2016","author":"Gomez-Hernandez","year":"2016","journal-title":"Int. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.vph.2023.107210_bb0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ihj.2015.07.033","article-title":"Calcific aortic valve disease: is it another face of atherosclerosis?","volume":"67","author":"Sathyamurthy","year":"2015","journal-title":"Indian Heart J."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0230","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijcard.2014.08.037","article-title":"Obesity paradox in patients with aortic valve stenosis. Protective effect of body mass index independently of age, disease severity, treatment modality and non-cardiac comorbidities","volume":"176","author":"Rossi","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.vph.2023.107210_bb0235","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.eurheartj.a060602","article-title":"Factors associated with calcific aortic valve degeneration in the elderly","volume":"15","author":"Lindroos","year":"1994","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.vph.2023.107210_bb0240","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2013.04.081","article-title":"Effect of overweight and obesity on cardiovascular events in asymptomatic Aortic stenosis: a SEAS substudy (simvastatin ezetimibe in Aortic stenosis)","volume":"62","author":"Rogge","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0245","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.vph.2023.107210_bb0250","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jacc.2013.05.047","article-title":"The obesity paradox in Aortic stenosis: to be or not to be\u2217","volume":"62","author":"Dumesnil","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2023.107210_bb0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13098-017-0285-2","article-title":"Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis","volume":"9","author":"Mancio","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"issue":"8","key":"10.1016\/j.vph.2023.107210_bb0260","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacc.2013.09.072","article-title":"Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox","volume":"63","author":"Shah","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0265","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00019501-200509000-00007","article-title":"Aortic valve calcification: association with bone mineral density and cardiovascular risk factors","volume":"16","author":"Aksoy","year":"2005","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0270","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.ATV.0000255952.47980.c2","article-title":"Aortic valve calcification: determinants and progression in the population","volume":"27","author":"Messika-Zeitoun","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.vph.2023.107210_bb0275","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10654-014-9936-x","article-title":"Assessment of risk factors for developing incident aortic stenosis: the Troms\u00f8 study","volume":"29","author":"Eveborn","year":"2014","journal-title":"Eur. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.vph.2023.107210_bb0280","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1161\/ATVBAHA.114.304015","article-title":"Carotid plaque, intima-media thickness, and incident aortic stenosis: a prospective cohort study","volume":"34","author":"Martinsson","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2023.107210_bb0285","doi-asserted-by":"crossref","first-page":"2174657","DOI":"10.1155\/2016\/2174657","article-title":"Predominance of abdominal visceral adipose tissue reflects the presence of Aortic valve calcification","volume":"2016","author":"Oikawa","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"28","key":"10.1016\/j.vph.2023.107210_bb0290","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehx140","article-title":"Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies","volume":"38","author":"Larsson","year":"2017","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.vph.2023.107210_bb0295","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/db08-1515","article-title":"Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the multi-ethnic study of atherosclerosis (MESA)","volume":"58","author":"Katz","year":"2009","journal-title":"Diabetes"},{"issue":"9888","key":"10.1016\/j.vph.2023.107210_bb0300","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurheartj\/ehz388","article-title":"Body mass index and body composition in relation to 14 cardiovascular conditions in UK biobank: a Mendelian randomization study","volume":"41","author":"Larsson","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2023.107210_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0315","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/cvr\/cvz062","article-title":"The epicardial adipose tissue and the coronary arteries: dangerous liaisons","volume":"115","author":"Madonna","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2023.107210_bb0320","article-title":"Inflammation and cardiovascular diseases in the elderly: the role of Epicardial adipose tissue","volume":"9","author":"Conte","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.vph.2023.107210_bb0325","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","article-title":"Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features","volume":"22","author":"Iacobellis","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0330","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","article-title":"Epicardial fat: properties, function and relationship to obesity","volume":"8","author":"Rabkin","year":"2007","journal-title":"Obes. Rev."},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0335","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrendo.2015.58","article-title":"Local and systemic effects of the multifaceted epicardial adipose tissue depot","volume":"11","author":"Iacobellis","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.vph.2023.107210_bb0340","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10517-017-3860-5","article-title":"Adipokine and cytokine profiles of Epicardial and subcutaneous adipose tissue in patients with coronary heart disease","volume":"163","author":"Gruzdeva","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0345","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/j.2040-4603.2017.tb00767.x","article-title":"Role of Epicardial adipose tissue in health and disease: a matter of fat?","volume":"7","author":"Gaborit","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.vph.2023.107210_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2021.666260","article-title":"Aging effects on Epicardial adipose tissue","volume":"2","author":"Iacobellis","year":"2021","journal-title":"Front Aging"},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0355","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.archger.2010.06.016","article-title":"Comparison of epicardial adipose tissue (EAT) thickness and anthropometric measurements in metabolic syndrome (MS) cases above and under the age of 65","volume":"52","author":"Karadag","year":"2011","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"4","key":"10.1016\/j.vph.2023.107210_bb0360","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.recesp.2016.07.025","article-title":"Epicardial adipose tissue in the general middle-aged population and its association with metabolic syndrome","volume":"70","author":"Calabuig","year":"2017","journal-title":"Revista espanola de cardiologia (English ed.)"},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0365","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.atherosclerosis.2010.06.044","article-title":"Age and sex mediated changes in epicardial fat adipokines","volume":"212","author":"Fei","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2023.107210_bb0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2015.03.201","article-title":"Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis","volume":"186","author":"Parisi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2023.107210_bb0375","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jsbmb.2015.05.001","article-title":"Lazaroid U-74389G inhibits the osteoblastic differentiation of IL-1\u03b2-indcued aortic valve interstitial cells through glucocorticoid receptor and inhibition of NF-\u03baB pathway","volume":"152","author":"Sun","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.vph.2023.107210_bb0380","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yjmcc.2014.02.014","article-title":"P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease","volume":"72","author":"El Husseini","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.vph.2023.107210_bb0385","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2016.07.012","article-title":"Relation between Epicardial adipose and Aortic valve and mitral annular calcium determined by computed tomography in subjects aged >\/=65 years","volume":"118","author":"Alnabelsi","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0390","first-page":"262","article-title":"Epicardial adipose tissue thickness independently predicts severe Aortic valve stenosis","volume":"26","author":"Mahabadi","year":"2017","journal-title":"J Heart Valve Dis"},{"issue":"3","key":"10.1016\/j.vph.2023.107210_bb0395","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0218492318760692","article-title":"Correlation between epicardial fat thickness and aortic valve sclerosis","volume":"26","author":"Nabati","year":"2018","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.vph.2023.107210_bb0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2019.01.068","article-title":"Epicardial adipose tissue volume is associated with adverse outcomes after transcatheter aortic valve replacement","volume":"286","author":"Eberhard","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2023.107210_bb0405","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.yjmcc.2019.05.012","article-title":"Correlational study on altered epicardial adipose tissue as a stratification risk factor for valve disease progression through IL-13 signaling","volume":"132","author":"Vianello","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.vph.2023.107210_bb0410","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2019.11.015","article-title":"Epicardial adipose tissue volume and annexin A2\/fetuin-a signalling are linked to coronary calcification in advanced coronary artery disease: computed tomography and proteomic biomarkers from the EPICHEART study","volume":"292","author":"Mancio","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.vph.2023.107210_bb0415","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2023.107210_bb0420","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2147\/DMSO.S253632","article-title":"Bone morphogenetic Protein-2 and Osteopontin gene expression in Epicardial adipose tissue from patients with coronary artery disease is associated with the presence of calcified atherosclerotic plaques","volume":"13","author":"Luna-Luna","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107482","article-title":"Impaired osteoblast differentiation in annexin A2- and -A5-deficient cells","volume":"9","author":"Genetos","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vph.2023.107210_bb0430","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/oby.21571","article-title":"Bone morphogenetic protein 2 (BMP2) may contribute to partition of energy storage into visceral and subcutaneous fat depots","volume":"24","author":"Guiu-Jurado","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.vph.2023.107210_bb0435","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/db11-1419","article-title":"The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans","volume":"61","author":"Gustafson","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2023.107210_bb0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcmg.2018.06.025","article-title":"Epicardial adipose tissue and myocardial fibrosis in aortic stenosis relationship with symptoms and outcomes","volume":"vol. 12","author":"Davin","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"8","key":"10.1016\/j.vph.2023.107210_bb0445","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjcard.2004.06.075","article-title":"Relation between epicardial adipose tissue and left ventricular mass","volume":"94","author":"Iacobellis","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0450","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10554-018-1477-z","article-title":"Epicardial fat amount is associated with the magnitude of left ventricular remodeling in aortic stenosis","volume":"35","author":"Coisne","year":"2019","journal-title":"Int. J. Card. Imaging"},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0455","first-page":"1080","article-title":"Visceral adiposity and left ventricular mass and function in patients with aortic stenosis: the PROGRESSA study","volume":"30","author":"Capoulade","year":"2014","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.vph.2023.107210_bb0460","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.acvd.2019.06.005","article-title":"Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis","volume":"112","author":"Arangalage","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0465","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","article-title":"Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation","volume":"12","author":"Hao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.vph.2023.107210_bb0470","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/ehf2.12837","article-title":"Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation","volume":"7","author":"Hoffmann","year":"2020","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.vph.2023.107210_bb0475","first-page":"1348913","article-title":"PCSK9 expression in Epicardial adipose tissue: molecular association with local tissue inflammation","author":"Dozio","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.vph.2023.107210_bb0480","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCIMAGING.113.000559","article-title":"Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis","volume":"6","author":"Mahmod","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.vph.2023.107210_bb0485","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2018.06.106","article-title":"Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue","volume":"274","author":"Parisi","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"23","key":"10.1016\/j.vph.2023.107210_bb0490","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.vph.2023.107210_bb0495","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.vph.2023.107210_bb0500","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.vph.2023.107210_bb0505","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2174\/1568026619666190809094203","article-title":"A review of PCSK9 inhibitors and their effects on cardiovascular diseases","volume":"19","author":"Chen","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.vph.2023.107210_bb0510","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L loss-of-function mutation reduces lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"36","key":"10.1016\/j.vph.2023.107210_bb0515","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/eurheartj\/ehv251","article-title":"The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen general population study","volume":"36","author":"Mortensen","year":"2015","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.vph.2023.107210_bb0520","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of Proprotein convertase Subtilisin\/Kexin type 9 inhibition and Aortic stenosis in the FOURIER trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189123000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:22:55Z","timestamp":1761528175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189123000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":104,"alternative-id":["S1537189123000708"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2023.107210","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of disease","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2023.107210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107210"}}